Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pharyngitis01:23

Chronic Pharyngitis

12.2K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
12.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

745
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
745
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

808
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
808
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

375
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
375
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

742
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
742
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-test probability determines optimal ANA screening strategy: a risk-stratified comparison of indirect immunofluorescence and CTD screen assay.

Clinical chemistry and laboratory medicine·2026
Same author

Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 Study.

EJHaem·2026
Same author

KCa3.1 mediates radioresistance of silver nanoparticles in human glioblastoma cells.

Pflugers Archiv : European journal of physiology·2026
Same author

Neuroinflammatory changes in acute myeloid leukemia: Evidence for blood-brain barrier disruption and glial activation.

HemaSphere·2026
Same author

Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab.

Frontiers in immunology·2026
Same author

Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Cancers·2026

Related Experiment Video

Updated: Feb 7, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.5K

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Emanuela Rosati1, Stefano Baldoni2, Filomena De Falco3

  • 1Department of Experimental Medicine, Biosciences and Medical Embryology Section, University of Perugia, Perugia, Italy.

Frontiers in Oncology
|July 13, 2018
PubMed
Summary

NOTCH1 mutations are key drivers in chronic lymphocytic leukemia (CLL), impacting patient outcomes. Targeting NOTCH1 signaling offers a promising therapeutic strategy for this B-cell neoplasm.

Keywords:
NOTCH1chronic lymphocytic leukemiagene mutationprognostic biomarkertargeted therapy

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.2K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.6K

Related Experiment Videos

Last Updated: Feb 7, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.5K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.2K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.6K

Area of Science:

  • Oncology
  • Hematology
  • Molecular Biology

Background:

  • Chronic lymphocytic leukemia (CLL) is a heterogeneous B-cell neoplasm with unpredictable clinical trajectories.
  • Genomic and molecular research has elucidated significant heterogeneity in CLL, correlating with clinical diversity.
  • NOTCH1 signaling pathway and its mutations are increasingly recognized for their critical role in CLL pathogenesis.

Purpose of the Study:

  • To review recent advancements in understanding NOTCH1 signaling in CLL pathophysiology.
  • To analyze the clinical significance of NOTCH1 mutations in CLL through retrospective and prospective studies.
  • To explore therapeutic strategies targeting NOTCH1 inhibition in CLL.

Main Methods:

  • Literature review of genomic, molecular, and clinical studies on NOTCH1 in CLL.
  • Analysis of data from retrospective and prospective clinical trials.
  • Overview of current NOTCH1-directed therapeutic approaches.

Main Results:

  • NOTCH1 mutations are prevalent in CLL and associated with specific clinical features.
  • Deregulated NOTCH1 signaling contributes to the survival and proliferation of CLL cells.
  • Clinical trials show varying impacts of NOTCH1 mutations on treatment response and prognosis.

Conclusions:

  • NOTCH1 mutations represent important biomarkers in CLL.
  • Targeting NOTCH1 signaling is a rational therapeutic approach for CLL.
  • Further research and clinical trials are needed to optimize NOTCH1-directed therapies for CLL patients.